TY - JOUR
T1 - Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing
AU - Rossetti, Sandro
AU - Hopp, Katharina
AU - Sikkink, Robert A.
AU - Sundsbak, Jamie L.
AU - Lee, Yean Kit
AU - Kubly, Vickie
AU - Eckloff, Bruce W.
AU - Ward, Christopher J.
AU - Winearls, Christopher G.
AU - Torres, Vicente E.
AU - Harris, Peter C.
PY - 2012/5
Y1 - 2012/5
N2 - Mutations in two large multi-exon genes, PKD1 and PKD2, cause autosomal dominant polycystic kidney disease (ADPKD). The duplication of PKD1 exons 1-32 as six pseudogenes on chromosome 16, the high level of allelic heterogeneity, and the cost of Sanger sequencing complicate mutation analysis, which can aid diagnostics of ADPKD. We developed and validated a strategy to analyze both the PKD1 and PKD2 genes using next-generation sequencing by pooling long-range PCR amplicons and multiplexing barcoded libraries. We used this approach to characterize a cohort of 230 patients with ADPKD. This process detected definitely and likely pathogenic variants in 115 (63%) of 183 patients with typical ADPKD. In addition, we identified atypical mutations, a gene conversion, and one missed mutation resulting from allele dropout, andwe characterized the pattern of deep intronic variation for both genes. In summary, this strategy involving next-generation sequencing is a model for future genetic characterization of large ADPKD populations.
AB - Mutations in two large multi-exon genes, PKD1 and PKD2, cause autosomal dominant polycystic kidney disease (ADPKD). The duplication of PKD1 exons 1-32 as six pseudogenes on chromosome 16, the high level of allelic heterogeneity, and the cost of Sanger sequencing complicate mutation analysis, which can aid diagnostics of ADPKD. We developed and validated a strategy to analyze both the PKD1 and PKD2 genes using next-generation sequencing by pooling long-range PCR amplicons and multiplexing barcoded libraries. We used this approach to characterize a cohort of 230 patients with ADPKD. This process detected definitely and likely pathogenic variants in 115 (63%) of 183 patients with typical ADPKD. In addition, we identified atypical mutations, a gene conversion, and one missed mutation resulting from allele dropout, andwe characterized the pattern of deep intronic variation for both genes. In summary, this strategy involving next-generation sequencing is a model for future genetic characterization of large ADPKD populations.
UR - http://www.scopus.com/inward/record.url?scp=84860611105&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860611105&partnerID=8YFLogxK
U2 - 10.1681/ASN.2011101032
DO - 10.1681/ASN.2011101032
M3 - Article
C2 - 22383692
AN - SCOPUS:84860611105
SN - 1046-6673
VL - 23
SP - 915
EP - 933
JO - Journal of the American Society of Nephrology : JASN
JF - Journal of the American Society of Nephrology : JASN
IS - 5
ER -